NEW YORK (GenomeWeb News) – Roche today reported that its Diagnostics division had fourth-quarter 2007 revenues of 2.5 billion Swiss francs ($2.3 billion), an 8.4 percent gain on revenues of CHF 2.3 billion in the fourth quarter of 2006.
For full-year 2007, Roche Diagnostics’ sales increased 7 percent to CHF 9.35 billion from CHF 8.75 billion in 2006. The firm said its share of the entire global diagnostics market is around 19 percent, which would make it the top player in the industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.